Nonadherence with prescribed drug regimens is a pervasive medical problem. Multiple variables affecting physicians and patients contribute to nonadherence, which negatively affects treatment outcomes. In patients with hypertension, medication nonadherence is a significant, often unrecognized, risk factor that contributes to poor blood pressure control.
September 2007
| Munger MA, Van Tassell BW, LaFleur JThe authors describe a study that tests 3 different interventions in a randomized controlled trial using home BP telemedicine monitoring.
June 2007
| Bosworth HB, Olsen MK, McCant F, Harrelson M, Gentry P, Rose C, Goldstein MK, Hoffman BB, Powers B, Oddone EZThe aim of this study was to assess the impact of telemonitoring of medication adherence on symptomatology and service use in patients with schizophrenia.
December 2005
| Frangou S, Sachpazidis I, Stassinakis A, Sakas GThe authors updated a review summarizing the results of randomized controlled trials (RCTs) of interventions to help patients follow prescriptions for medications for medical problems, including mental disorders but not addictions.
2005
| Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HPThe American Pharmacists Association (APhA) convened a roundtable discussion on patient adherence programs.
October 2004
| American Pharmacists AssociationThis report is part of the work of the Adherence to Long-term Therapies Project, a global initiative launched in 2001 by the Noncommunicable Diseases and Mental Health Cluster of the World Health Organization.
July 2003
| World Health Organization